Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized placebo-controlled trial.

Nat Med · 2025 · PMC12705446 · PMID 41023483

Europe PMC DOI

hedged sentence

0.2880

closest p · 5.8× alpha

0.2880

boldest claim

The sentences

did not reach statistical significanceP = 0.288not close (p > 0.1)

Finally, while the difference in time to treatment failure in phase D did not reach statistical significance, the observed trend strongly favors VER-01 with a hazard ratio of 0.75 ( P = 0.288).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.